Lupin shares in focus as USFDA inspection at Somerset facility concludes with no observationsEarlier in January, the company received the Establishment Inspection Report (EIR) from USFDA for its Pithampur Unit-1 manufacturing facili...
03 Feb, 2025, 09.14 AM IST
Buy Lupin, target price Rs 2300: Prabhudas LilladherLupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 93499.24 Crore) operating in Pharmaceuticals s...
09 Aug, 2024, 09.23 AM IST
Buy Lupin, target price Rs 1325: Axis SecuritiesLupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the yea...
20 Nov, 2023, 10.40 AM IST
Sell Lupin, target price Rs 990: Motilal OswalLupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 53688.88 Crore) operating in Pharmaceuticals s...
10 Nov, 2023, 10.30 AM IST
Buy Lupin, target price Rs 1165: ICICI DirectLupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 50629.93 Crore) operating in Pharmaceuticals s...
29 Aug, 2023, 09.30 AM IST
LUPIN: Short-term sideways to bearishLupin’s daily trend is bullish, however, in the last few trading sessions, it is showing weaknesses. In the last trading session, it closed...
09 Dec, 2022, 10.46 AM IST
Lupin rises over 3% as Brazil subsidiary acquires 9 brands from Bausch HealthThe acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their relia...
29 Nov, 2022, 12.21 PM IST
Lupin gets warning letter from FDA for Tarapur facility, stock falls over 2%“We wish to inform you that the company has received a warning letter from the US FDA for the company’s Tarapur, Maharashtra facility. The ...
29 Sep, 2022, 12.55 PM IST
Lupin skids as failed USFDA specifications lead to recalls of 2 drugsThe company’s scrip fell to a low of Rs 937.15 as against Rs 951.80 at previous close on the National Stock Exchange.
17 Jan, 2022, 10.26 AM IST
Lupin shares jump 10% in a sudden move; here's whyThe US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI), the Mumbai-headquartered ...
14 Dec, 2021, 11.06 AM IST
Lupin Q2 results: Firms posts Rs 2,095 crore loss due to one-off impairmentsDuring the quarter, the company booked a provision of Rs 1879.6 crore towards litigation and settlement related to diabetic drug Glumetza c...
28 Oct, 2021, 12.16 PM IST
Lupin gains 1% on tentative USFDA nod to generic BrexpiprazoleAt 09:30 hours (IST), Lupin’s shares traded at Rs 957.70 on the National Stock Exchange, up 1.11% from previous close.
07 Oct, 2021, 11.05 AM IST
Licence to sell cancer drug biggest opportunity for Dr Reddy’s in US market: Nirmal Bang‘On a very conservative basis, the drug can add about $300 million to their sales in FY23-FY24.’
18 Sep, 2020, 11.44 AM IST
Lupin stock vaults to 52-week high on generic launch of Novartis' DiovanThe stock has gained 25% in the last one year – and has been one of the best performing stocks among the frontline pharma companies.
25 Mar, 2013, 12.48 PM IST
- Lupin relentlessly compounding at 17-18%: Angel Broking
It is relentlessly compounding at 17-18%, which is a healthy figure and more importantly there is a talk of some inorganic development in L...
01 Aug, 2012, 11.10 AM IST
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning trade
Shares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
24 Aug, 2011, 11.06 AM IST
- Cipla, Lupin shares surge in morning trade on bourses
Shares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
24 Aug, 2011, 11.03 AM IST